Recent Updates
  • Genomic Health update
    3 days ago

    Great weekend raising ‪#‎prostatecancer‬ awareness with our ‪#‎ProstateDecision‬ partners ZERO - The End of Prostate Cancer, @menshlthnetwork, Prostate Health Education Network, and Joe Torre! Thrill to see former NFL player and #prostatecancer survivor @mcmillantodd deliver the official game ball for the Los Angeles Angels of Anaheim vs. Seattle Mariners game!

  • Genomic Health update
    11 days ago

    Hats off to Dads! We’re celebrating ‪#‎FathersDay‬ with @Twins and @Cubs fans at Target Field. Stop by our booth to pick up a baseball cap and learn more about making the right treatment decision for ‪#‎prostatecancer‬. You can find out more by checking out http://glassdoor.com/slink.htm?key=vIWWi.

    Your Prostate Your Decision - Joe Torre Talks Treatment | MyProstateCancerTreatment.org

    Half of newly diagnosed men have low-risk prostate cancer that is unlikely to spread, yet 90% receive aggressive immediate treatment. Active surveillance is an appropriate treatment plan for many, yet few men consider it as an option - in fact, a recent study shows only 10% of men link it to prostate cancer.

0

Genomic Health Video

Provided by employer [?]

Loading...

Genomic Health – Why Work For Us?

undefined

Company Overview

Genomic Health, a global health company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-basedclinical laboratory services. To that end, the company conducts sophisticated genomic research to develop clinically-validated molecular diagnostics which provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions.

At Genomic Health, we developed and follow a highly specialized process that not only adheres rigorously to CAP (College of American Pathologists) standards and CLIA (Clinical Laboratory Improvement Amendments) regulations, but also incorporates numerous real-time quality checks and periodic proficiency testing designed to produce a high level of accuracy in information that we deliver to physicians and patients.

Product Overview

The company's lead product, the Oncotype DX breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS). In addition to this widely adopted test, Genomic Health provides theOncotype DX colon cancer test, the first multi-gene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease and the Oncotype DX prostate cancer test, which predicts disease aggressiveness in men with low risk disease. Genomic Health has a robust pipeline focused on developing tests to further optimize the treatment of breast, colon and prostate cancers, as well as the treatment of renal cancer. 

undefined

Life at Genomic Health

At Genomic Health, you have the opportunity to make a difference in the lives of patients with cancer while developing your career potential. You will be encouraged to connect, communicate and innovate in a supportive environment characterized by transparency, clarity, and collaboration. From frequent and real-time feedback to a reward system that recognizes achievements and results, you will find that every contribution is valued and excellence is our goal. We celebrate accomplishments, promote career growth, and encourage a healthy work/life balance.

Genomic Health Reviews

3.2
Rating Trends
Recommend to a friend
Approve of CEO
Genomic Health President & CEO Kim Popovits
Kim Popovits
27 Ratings
  • Featured Review

    Helpful (1)

    Mission Driven from Product to Personnel

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Contractor - Anonymous Contractor
    Current Contractor - Anonymous Contractor

    I have been working at Genomic Health as a contractor (Less than a year)

    Recommends
    Positive Outlook
    Approves of CEO
    Recommends
    Positive Outlook
    Approves of CEO

    Pros

    The fact I know everyone is working very hard to improve our patients lives in tandem with the approachable upper management keeps me coming back day after day with a smile.

    Cons

    You wont find kitchens full of goodies like Google or Facebook, but if that is what gets you to work - you probably are not challenging yourself.


Genomic Health Interviews

Interview Experience

Interview Experience

63%
27%
9%

Getting an Interview

Getting an Interview

36%
36%
9%

Interview Difficulty

2.9
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    No Offer
    Neutral Experience
    Average Interview

    Application

    I applied online. The process took 2+ monthsinterviewed at Genomic Health in March 2015.

    Interview

    The interview took around 45 minutes with very in-depth questions about my project at school. Not many questions about my past experience. I think that is the way the interviewer figured out whether I did contribute anything for the project and whether I really led the team as I mentioned. They had not come back to me after that although I pinged them sometimes. Thus I think that is the way they say "No".

    Interview Questions

Genomic Health Awards & Accolades

Something missing? Add an award
Winning "W" Company, 2020 Women on Boards, 2013

Additional Info

Website www.genomichealth.com
Headquarters Redwood City, CA
Size 500 to 999 Employees
Founded 2000
Type Company - Public (GHDX)
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year

About Genomic Health

Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is... More

Work at Genomic Health? Share Your Experiences

Genomic Health

 
Click to Rate
or